WallStSmart

Aveanna Healthcare Holdings Inc (AVAH)vsFresenius Medical Care Corporation (FMS)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Fresenius Medical Care Corporation generates 668% more annual revenue ($19.36B vs $2.52B). AVAH leads profitability with a 10.4% profit margin vs 4.9%. AVAH trades at a lower P/E of 7.0x. AVAH earns a higher WallStSmart Score of 62/100 (C+).

AVAH

Buy

62

out of 100

Grade: C+

Growth: 8.7Profit: 7.5Value: 5.7Quality: 3.5
Piotroski: 4/9Altman Z: 0.95

FMS

Buy

50

out of 100

Grade: C-

Growth: 2.7Profit: 5.0Value: 8.7Quality: 6.0
Piotroski: 6/9Altman Z: 1.96
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

AVAHSignificantly Overvalued (-84.3%)

Margin of Safety

-84.3%

Fair Value

$4.33

Current Price

$8.48

$4.15 premium

UndervaluedFair: $4.33Overvalued
FMSUndervalued (+68.9%)

Margin of Safety

+68.9%

Fair Value

$77.34

Current Price

$23.24

$54.10 discount

UndervaluedFair: $77.34Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

AVAH4 strengths · Avg: 9.5/10
P/E RatioValuation
7.0x10/10

Attractively priced relative to earnings

Return on EquityProfitability
36.8%10/10

Every $100 of equity generates 37 in profit

EPS GrowthGrowth
612.0%10/10

Earnings expanding 612.0% YoY

Revenue GrowthGrowth
15.9%8/10

15.9% revenue growth

FMS3 strengths · Avg: 8.7/10
Price/BookValuation
0.8x10/10

Reasonable price relative to book value

PEG RatioValuation
0.848/10

Growing faster than its price suggests

P/E RatioValuation
12.4x8/10

Attractively priced relative to earnings

Areas to Watch

AVAH4 concerns · Avg: 2.0/10
Market CapQuality
$1.84B3/10

Smaller company, higher risk/reward

Free Cash FlowQuality
$-208,0002/10

Negative free cash flow — burning cash

Altman Z-ScoreHealth
0.952/10

Distress zone — elevated risk

Debt/EquityHealth
6.261/10

Elevated debt levels

FMS4 concerns · Avg: 3.0/10
Altman Z-ScoreHealth
1.964/10

Grey zone — moderate risk

Return on EquityProfitability
7.1%3/10

ROE of 7.1% — below average capital efficiency

Profit MarginProfitability
4.9%3/10

4.9% margin — thin

Revenue GrowthGrowth
-5.5%2/10

Revenue declined 5.5%

Comparative Analysis Report

WallStSmart Research

Bull Case : AVAH

The strongest argument for AVAH centers on P/E Ratio, Return on Equity, EPS Growth. Revenue growth of 15.9% demonstrates continued momentum.

Bull Case : FMS

The strongest argument for FMS centers on Price/Book, PEG Ratio, P/E Ratio. PEG of 0.84 suggests the stock is reasonably priced for its growth.

Bear Case : AVAH

The primary concerns for AVAH are Market Cap, Free Cash Flow, Altman Z-Score. Debt-to-equity of 6.26 is elevated, increasing financial risk.

Bear Case : FMS

The primary concerns for FMS are Altman Z-Score, Return on Equity, Profit Margin. Thin 4.9% margins leave little buffer for downturns.

Key Dynamics to Monitor

AVAH profiles as a growth stock while FMS is a value play — different risk/reward profiles.

AVAH carries more volatility with a beta of 1.93 — expect wider price swings.

AVAH is growing revenue faster at 15.9% — sustainability is the question.

FMS generates stronger free cash flow (37M), providing more financial flexibility.

Bottom Line

AVAH scores higher overall (62/100 vs 50/100) and 15.9% revenue growth. FMS offers better value entry with a 68.9% margin of safety. Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Aveanna Healthcare Holdings Inc

HEALTHCARE · MEDICAL CARE FACILITIES · USA

Aveanna Healthcare Holdings Inc., a diversified home care platform company, offers private duty nursing (PDN) services, adult home health and palliative care, pediatric home therapy, and enteral nutrition services in the United States. The company is headquartered in Atlanta, Georgia.

Fresenius Medical Care Corporation

HEALTHCARE · MEDICAL CARE FACILITIES · USA

Fresenius Medical Care AG & Co. KGaA provides dialysis care and related dialysis care services in Germany, North America and internationally. The company is headquartered in Bad Homburg, Germany.

Visit Website →

Want to dig deeper into these stocks?